20 June 2013
Keywords: connetics, start, ph, iii, program, steroid, corp
Article | 04 April 2005
Connetics Corp, a California, USA-based specialty pharmaceutical firm that develops and commercializes dermatology products, has initiated a
Phase III clinical ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 April 2005
25 April 2005
19 June 2013
© 2013 thepharmaletter.com